Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ACIP
Pharma
GSK's Arexvy shows promise in younger adults
Results from two trials showed that GSK’s RSV vaccine Arexvy has potential in younger adults with certain risk factors.
Kevin Dunleavy
Oct 24, 2024 10:32am
CDC panel endorses broader pneumococcal vaccine use
Oct 23, 2024 5:40pm
GSK rolls out positive 3-year data on RSV vaccine Arexvy
Oct 8, 2024 11:29am
With new CDC guidelines, RSV market value falls sharply: report
Jul 29, 2024 12:04pm
Merck's new Capvaxive scores key CDC vaccine panel endorsement
Jun 28, 2024 11:44am
CDC backs Pfizer's maternal Abrysvo to protect infants from RSV
Sep 25, 2023 11:08am